Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
Fitoterapia ; 95: 8-15, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24594240

RESUMEN

Infusions of Picrolemma sprucei roots, stems and leaves are used in traditional medicine throughout the Amazon region from the Guianas to Brazil and Peru in the treatment of gastritis, intestinal helminths and malaria. As there are no studies describing its mode of action in providing a gastroprotective effect, we determined herein that one of the main constituents found in P. sprucei infusions, the quassinoid isobrucein B (IsoB), reduces some of the pathophysiological effects in a mouse model of non-steroidal anti-inflammatory drug (NSAID)-induced gastritis and provides mechanisms of action. Then, IsoB (1.17 g) was isolated from the roots and stems (6.5 kg) of P. sprucei. Its structure was confirmed by 1D and 2D (1)H and (13)C NMR, ESI-tof-MS, IR and UV. C57BL/6 strain mice were subcutaneously injected with IsoB (0.5-5 mg kg(-1)) or vehicle before oral administration of indomethacin and sacrificed later at different time points. Gastric damage was assessed by measuring lesion length. Leukocyte migration was evaluated based on leukocyte rolling and adhesion using intravital microscopy in the mesenteric microcirculation and tissue MPO activity. Stomach extract cytokine (TNFα, IL-1ß and KC/CXCL1) and prostaglandin E2 (PGE2) levels were measured by ELISA and RIA, respectively. IsoB pre-treatment (0.5-5.0 mg kg(-1)) significantly reduced the formation of indomethacin-induced stomach lesions in a dose-dependent manner. The decrease in stomach lesions was associated with less observed leukocyte rolling, decreased leukocyte adhesion and less neutrophil infiltration (MPO activity). IsoB (1 mg kg(-1)) pre-treatment did not prevent indomethacin-induced decreases in stomach PGE2 levels. However, IL-1ß and KC/CXCL1 levels were inhibited by this same IsoB dosage, whereas TNF-α was unchanged. IsoB may be a prototypic compound to provide protective effects against NSAID-induced gastritis and possibly other gastropathies. Moreover, IsoB gastroprotective action may be due to a reduction in IL-1ß and KC/CXCL1 production/release and leukocyte rolling, adhesion and migration.


Asunto(s)
Gastritis/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Cuassinas/uso terapéutico , Simaroubaceae/química , Animales , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/metabolismo , Adhesión Celular/efectos de los fármacos , Citocinas/metabolismo , Dinoprostona/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Mucosa Gástrica/efectos de los fármacos , Gastritis/inducido químicamente , Indometacina/metabolismo , Leucocitos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Estructura Molecular , Neutrófilos/efectos de los fármacos , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Raíces de Plantas/química , Tallos de la Planta/química , Plantas Medicinales , Cuassinas/química , Cuassinas/aislamiento & purificación
2.
Acta amaz ; 39(1): 229-231, mar. 2009. ilus
Artículo en Inglés | LILACS | ID: lil-515768

RESUMEN

Quassinoids neosergeolide and isobrucein B, obtained from Picrolemma sprucei, have proven in vitro antitumor, antimalarial, anthelminthic, cytotoxic, insecticide and leishmanicidal activities. There is interest in the in vivo pharmacological study of these natural compounds and their semi-synthetic derivatives, however, the quantities obtained in previous extraction processes have been shown to be a limiting factor for continuation of these studies. Herein, we describe a method for obtaining grams of these quassinoids whose purification relies only on recrystallization.


Os quassinóides neosergeolida e isobruceína B, obtidos de Picrolemma sprucei, possuem atividades antitumoral, antimalárica, anti-helmíntica, citotóxica, inseticida e anti-leishmania comprovadas em estudos in vitro. Há interesse no estudo farmacológico in vivo dessas substâncias naturais e de seus derivados semi-sintéticos, porém a quantidade obtida nos processos de extração tem se mostrado um fator limitante à continuação desses estudos. No presente trabalho, descrevemos um método para obtenção de gramas desses quassinóides cuja purificação depende apenas de cristalização fracionada.


Asunto(s)
Simaroubaceae , Cuassinas
3.
Acta amaz ; 36(3): 327-330, jul.-set. 2006. tab
Artículo en Inglés | LILACS | ID: lil-441184

RESUMEN

1300 ppm (1.3 g / L), water and ethanol extracts prepared from stems or roots of Picrolemma sprucei Hook. f. were lethal (85-90 percent mortality) in vitro to Haemonchus contortus (Barber Pole Worm) larvae, a gastrointestinal nematode parasite found in domestic and wild ruminants. Neosergeolide and isobrucein B were isolated in 0.0083 and 0.0070 percent yield from dry, ground P. sprucei stems (0.89 kg). Neosergeolide, isobrucein B and the anthelmintic drug standard levamisole all caused comparable mortality rates (68-77 percent) in vitro to H. contortus at similar concentrations (81-86 ppm). The anthelmintic activity of P. sprucei infusions (teas), alcohol extracts, and neosergeolide and isobrucein B, has therefore been demonstrated for the first time.


Na concentração de 1300 ppm (1.3 g / L), extratos aquosos e etanólicos preparados a partir dos caules ou raízes de Picrolemma sprucei Hook. f. apresentaram letalidade (85-90 por cento de mortalidade) in vitro para Haemonchus contortus, um nematóide parasítico do aparelho gastrointestinal de ruminantes domesticos e silvestres. Neosergeolida e isobruceina B foram isoladas dos caules em rendimentos de 0.0083 and 0.0070 por cento, respectivamente. Essas últimas e a droga anti-helmíntica levamisole provocaram mortalidade semelhante in vitro (68-77 por cento) em H. contortus em concentrações semelhantes (81-86 ppm). A atividade anti-helmíntica in vitro de infusões e extratos alcoólicos dos caules, bem como da neosergeolida e isobruceina B isoladas de P. sprucei, foi demonstrada pela primeira vez.


Asunto(s)
Simaroubaceae , Haemonchus
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA